Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating TP53 Wild-Type Chronic Lymphocytic Leukemia
利用 Siremadlin 靶向 MDM2-p53 相互作用：一种治疗 TP53 野生型慢性淋巴细胞白血病的有前景的治疗策略
期刊:Cancers
影响因子:
doi:10.3390/cancers17020274
Erhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis, Helen Marr, Scott Marshall, Julie Irving, Elaine Willmore, John Lunec
